Lataa...
Molecular targeted therapies of renal cell carcinoma considering life stage of the patient: Two case reports
Molecular targeted therapies have markedly improved the prognosis of metastatic renal cell carcinoma (RCC) and patients are able to receive specific treatments depending on their condition. The cases of two patients who presented with large RCC with very different statuses were examined in the curre...
Tallennettuna:
| Julkaisussa: | Exp Ther Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844110/ https://ncbi.nlm.nih.gov/pubmed/29556268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.5882 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|